Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions (Q39445040)

12 September 2017

title

Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions (English)

1 reference

12 September 2017

0 references

1

Cornud F

1 reference

12 September 2017

7

Hélénon O

1 reference

12 September 2017

Belin X

2

1 reference

12 September 2017

Piron D

3

1 reference

12 September 2017

Chrétien Y

4

1 reference

12 September 2017

Flam T

5

1 reference

12 September 2017

Casanova JM

6

1 reference

12 September 2017

Méjean A

8

1 reference

12 September 2017

Thiounn N

9

1 reference

12 September 2017

Moreau JF

10

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

12 September 2017

1 reference

12 September 2017

volume

49

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

709-715

1 reference

Ultrasound guided transrectal core biopsies of the palpably abnormal prostate

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Palpable masses in the prostate: superior accuracy of US-guided biopsy compared with accuracy of digitally guided biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Value of random US-guided transrectal prostate biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

The Ability of Systematic Transrectal Ultrasound Guided Biopsy to Detect Prostate Cancer in Men with the Clinical Diagnosis of Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

The Inability of Prostate Specific Antigen Index to Enhance the Predictive Value of Prostate Specific Antigen in the Diagnosis of Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Prostate cancer and the role of color Doppler US

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Prostate: techniques, results, and potential applications of color Doppler US scanning

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Estimation of prostate cancer volume by transrectal ultrasound imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Diagnosis of prostate cancer: a personal view

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900632-2

7 January 2021

10.1016/S0090-4295(96)00632-2

Identifiers

DOI

1 reference

12 September 2017

1 reference